Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Apr;36(4):382-7.
doi: 10.1038/ng1329. Epub 2004 Mar 21.

ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating

Martin Bienengraeber  1 , Timothy M Olson, Vitaliy A Selivanov, Eva C Kathmann, Fearghas O'Cochlain, Fan Gao, Amy B Karger, Jeffrey D Ballew, Denice M Hodgson, Leonid V Zingman, Yuan-Ping Pang, Alexey E Alekseev, Andre Terzic
Affiliations

ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating

Martin Bienengraeber et al. Nat Genet. 2004 Apr.

Abstract

Stress tolerance of the heart requires high-fidelity metabolic sensing by ATP-sensitive potassium (K(ATP)) channels that adjust membrane potential-dependent functions to match cellular energetic demand. Scanning of genomic DNA from individuals with heart failure and rhythm disturbances due to idiopathic dilated cardiomyopathy identified two mutations in ABCC9, which encodes the regulatory SUR2A subunit of the cardiac K(ATP) channel. These missense and frameshift mutations mapped to evolutionarily conserved domains adjacent to the catalytic ATPase pocket within SUR2A. Mutant SUR2A proteins showed aberrant redistribution of conformations in the intrinsic ATP hydrolytic cycle, translating into abnormal K(ATP) channel phenotypes with compromised metabolic signal decoding. Defective catalysis-mediated pore regulation is thus a mechanism for channel dysfunction and susceptibility to dilated cardiomyopathy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
KATP channel mutations in dilated cardiomyopathy. (a) The regulatory SUR2A subunit (nucleotide-binding domains NBD1 and NBD2 with Walker A and B motifs and a linker L region) forms cardiac KATP channels by assembling with the pore-forming Kir6.2 subunit (transmembrane domains M1 and M2). Analysis of exon 38 in ABCC9 genomic DNA, which encodes the C terminus of the SUR2A protein, identified abnormal chromatograms indicative of mutations in individuals with dilated cardiomyopathy (DCM). Sequencing identified frameshift (Fs1524; individual 1) and missense (A1513T; individual 2) mutations. The family of individual 1 was unavailable for segregation analysis. The mutation in individual 2 was not present in the proband’s mother, suggestive of inheritance from the affected father (DNA was unavailable). (b) SUR2A residues encoded by exon 38 in wild-type and mutant ABCC9 sequences in humans and other species.
Figure 2
Figure 2
SUR2A mutant proteins, coexpressed with Kir6.2, alter KATP channel function. (a) Fs1524 and A1513T reduced KATP channel trafficking by ∼70% and ∼30%, probed immunologically by SUR surface expression in Xenopus laevis oocytes. (b) Single channel conductance and inward rectification (not shown) of wild-type and mutant channels, expressed in HEK293 cells, were identical, indicating that biophysical pore properties were intact. (c,d) Atomic model of SUR2A NBD2. Red, α-helix; blue, β-strand; yellow, Walker motifs (WA and WB). Missense A1513T (cyan) and frameshift L1524 (magenta) mutations frame the β-strand adjacent to Walker motifs that coordinate NBD2-mediated catalysis. Representative hydrogen bonds that stabilize Walker A and the associated C terminus β-strand are indicated by dashed green lines. Red, oxygen atoms; blue, nitrogen; mustard, sulfur (Cys1345). (e) Abnormal ATP-induced KATP channel inhibition in mutants. Channel inhibition was expressed relative to activity in the absence of ATP and measured at −60 mV in inside-out patches. Solid curves represent Hill equation fits of experimental data, with the ATP concentration required for half-inhibition (IC50) indicated for wild-type and mutant channels.
Figure 3
Figure 3
SUR2A NBD2 mutants have normal ATP binding but altered ATPase properties. (a) Affinity-purified mutant or wild-type SUR2A NBD2, cloned in-frame with maltose binding protein (MBP), on SDS gels. An antibody against the last 12 amino acids of SUR2A recognized the wild-type (WT) and A1513T mutant but not Fs1524, whereas an antibody raised against MBP reacted with all constructs. Molecular sizes are given in kDa. (b) The binding affinity of the fluorescent ATP analog TNP-ATP was similar for wild-type (WT) and mutant NBD2 in Scatchard analysis. Inset: Specific TNP-ATP binding-induced signal detected as difference between total and nonspecific (NS) fluorescence (F) of the ATP analog in the absence of NBD constructs. (c) The A1513T and Fs1524 NBD2 mutations reduced ATPase activity measured from γ-32P liberation after [γ-32P]ATP hydrolysis. WT, wild-type. (d,e) ATP and ADP dependence of NBD2 ATPase activities measured by spectrophotometry showed vmax values of 9.98 ± 0.34 min−1 in wild-type (WT), 6.07 ± 0.18 min−1 in A1513T and 5.69 ± 0.29 min−1 in Fs1524 with Michaelis-Menten constants at 0.11 ± 0.02, 0.094 ± 0.013 and 0.084 ± 0.010 mM, respectively (equation 3). The ATP-dependence of the NBD2 ATPase was determined at 0 ADP in the presence of creatine kinase (0.01 U ml−1) and creatine phosphate (5 mM). ADP-dependent inhibition of the NBD2 ATPase (at 2 mM ATP) was characterized by an ADP-dissociation constant (KADP) of 8.6 ± 0.3 μM in wild-type versus 24.9 ± 5.6 and 11.0 ± 1.5 in the A1513T and Fs1524 mutants, respectively (equation 5). (f) Both pre-steady state and steady-state reaction rates were altered by A1513T and Fs1524 mutations in stopped-flow experiments. Solid lines represent the fit of experimental data with the system of differential equations (equation 6), allowing evaluation of the rate kinetic constants of the NBD2 ATPase reaction. WT, wild-type.
Figure 4
Figure 4
Altered kinetics of the ATPase cycle lead to disrupted metabolic decoding by KATP channels. (a) Rate constants defining the SUR2A ATPase reaction were derived from pre-steady state kinetics of Pi liberation in wild-type (WT) and mutant NBD2 constructs (n = 4 each). (b) Lifetime distribution of individual conformations (equation 10) in wild-type (WT) and mutant NBD2 ATPase cycle. (c) Rate-limiting steps in the SUR2A ATPase cycle are ADP dissociation (k4) for wild-type (WT), Pi dissociation (k3) for Fs1524 and abnormally increased k4 for A1513T. Fs1524 has the lowest k04 rate constant defining ADP association. (d) In the absence of ADP, both NBD2 mutants have lower probability to adopt ATP-bound (PE-ATP) and higher probability to adopt ATP-bound (PΣADP) conformations in a wide range of ATP concentrations. PΣADP is the sum of E-ADP-Pi (PE-ADP-Pi) and E-ADP (PE-ADP) probabilities (equations 7-9). WT, wild-type. (e,f) ADP-induced modulation of probabilities in the NBD2 ATPase cycle intermediates determined as dPΣADP/d[ADP] and dPE-ATP/d[ADP] derivatives at different ATP levels. In response to ADP, PΣADP increases whereas PE-ATP decreases, defining the sign of respective derivatives. Both Fs1524 and A1513T diminished the ADP-responsiveness of PΣADP and PE-ATP. WT, wild-type. (g) ADP-scavenging creatine kinase (0.01 U ml−1, 5 mM creatine phosphate) accelerates the ATPase in the wild type (WT) but not in Fs1524 and A1513T mutants. Rate of Pi liberation was measured at 2 mM ATP using spectrophotometry. (h,i) After coexpression of Kir6.2, channel activity, at 0.3 mM ATP, in the presence and absence of 0.3 mM ADP was measured in wild-type (WT; n = 5) SUR2A and in Fs1524 (n = 4) and A1513T (n = 6) SUR2A mutants in inside-out patches. In addition to reduced ATP sensitivity, both mutants had blunted ADP channel response relative to KATP channel activity at zero nucleotide levels.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Inagaki N, et al. Reconstitution of IKATP: An inward rectifier subunit plus the sulfonylurea receptor. Science. 1995;270:1166–1170. - PubMed
    1. Inagaki N, et al. A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron. 1996;16:1011–1017. - PubMed
    1. Bienengraeber M, et al. ATPase activity of the sulfonylurea receptor: A catalytic function for the KATP channel complex. FASEB J. 2000;14:1943–1952. - PubMed
    1. Matsuo M, Tanabe K, Kioka N, Amachi T, Ueda K. Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B. J. Biol. Chem. 2000;275:28757–28763. - PubMed
    1. Zingman LV, et al. Signaling in channel/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K+ conductance. Neuron. 2001;31:233–245. - PubMed

Publication types